Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Cash ratio

Cash ratio at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
0.3×-1.2×
Alkermes logo
AlkermesALKS
0.6×-0.3×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
0.7×-0.5×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
3.8×-2.3×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
0.3×+0.2×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
0.9×+0.2×

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

cash and equivalents/total current liabilities=2.7×

Based on the most recent quarter.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s cash ratio?
Harmony Biosciences Holdings, Inc. (HRMY) reported cash ratio of 2.7× in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s cash ratio changed year-over-year?
Harmony Biosciences Holdings, Inc.'s cash ratio decreased by 2.9% year-over-year, from 2.8× to 2.7×.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s cash ratio has grown at a 11.9% compound annual growth rate (CAGR), from 1.7× to 3×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.